Brian Nichols is the co-founder of Angel Squad, a community where you’ll learn how to angel invest and get a chance to invest as little as $1k into Hustle Fund's top performing early-stage startups

Key Takeaways

• Anduril's last primary round set a $61 billion valuation in April 2026 at roughly $69 per share, led by Andreessen Horowitz and Thrive Capital. On the secondary market it trades near $98.32, a real-time market cap of about $87.24 billion, roughly a 43% premium to that round.
• This is the rare private name where demand outstrips supply, running about 1.7 to 1. That is why it trades up, not down.
• Revenue roughly doubled to about $1 billion in 2024 and again to about $2.1 billion in 2025, a figure both Notice and multiple outlets corroborate.
• That puts Anduril at roughly 29x revenue at the last round and about 41x on the secondary price. Rich for a hardware-heavy defense business, though below where Palantir trades.
• You cannot buy Anduril directly. Access is indirect only, through SPVs or forward purchase contracts, which changes your risk profile before you even pick a price.

Anduril is the anomaly in the current crop of pre-IPO names. Where most trade at discounts to their last round, Anduril trades at a 43% premium, with buyers lined up nearly two to one against sellers. The company has gone from a $14 billion valuation in 2024 to $61 billion in 2026, and the secondary market is marking it even higher. For anyone looking at Anduril pre-IPO stock, the first thing to understand is that you are paying up, and the second is that you can only get in sideways.

Whether it is a good buy at today's price depends far less on how you feel about defense tech and far more on how you enter: the structure, the rights, the price, and the path to liquidity.

This guide is written for the accredited investor sizing up private-market exposure, not for retail buyers waiting on a ticker. You will get how these shares actually work, what diligence matters, and what to confirm before you wire anything.

What Anduril Pre-IPO Shares Are (and What They Are Not)

Pre-IPO shares in a private company are usually existing shares sold by an employee, founder, or early investor in a secondary transaction. They are not publicly traded equity, and they carry no continuous pricing, no broad SEC reporting, and no automatic liquidity.

With Anduril there is an extra wrinkle that matters more than almost anything else in this guide. The company does not allow direct stock transfers at all. According to Notice, the only way to get exposure is indirectly, through a special purpose vehicle or a forward purchase contract. That means you are not buying Anduril shares in the normal sense. You are buying a position in a vehicle or a contract that references Anduril, which carries its own fees, its own counterparty questions, and its own layer of distance from the actual cap table. Hold that thought, because it shapes the entire deal.

The primary-versus-secondary distinction still applies. A primary round issues new shares and adds cash to the company. A secondary transfers ownership between private parties and funds nothing at Anduril. Do not treat a private listing like a public quote. There is no ticker and no continuous market, only negotiated transactions with limited disclosure.

What Is the Current Valuation of Anduril?

Anduril's last primary valuation is $61 billion, set in the roughly $5.1 billion Series H that closed in April 2026 at about $68.95 per share, with Andreessen Horowitz and Thrive Capital leading. That is a staggering climb: $14 billion in 2024, $30.5 billion in 2025, and $61 billion in 2026, a doubling in the last year alone.

The secondary market has pushed even higher. Shares trade near $98.32, which works out to a real-time market cap around $87.24 billion, roughly 43% above the last round. That premium is the whole tell. It says the market of private buyers believes the company is worth meaningfully more than its most recent, already-aggressive primary mark. When a secondary trades at a premium this wide, you are underwriting not just the company but the crowd's enthusiasm for it.

The business is defense technology built like a software company. Anduril makes autonomous systems, sensors, and its Lattice command-and-control platform, which fuses data from cameras, radars, and other sources to help operators detect and respond to threats. It also builds drones, underwater vehicles, and fixed surveillance systems for government customers. Founded in 2017, it now employs roughly 7,900 people, with total funding above $12 billion and backers including Founders Fund, Valor, Elad Gil, and Lightspeed alongside its recent leads.

How Does Anduril Generate Revenue?

Anduril sells hardware and software to the US government and allied militaries: autonomous systems, counter-drone systems, surveillance towers, and Lattice software licenses, typically through defense contracts and programs of record. Unlike a pure SaaS business, a meaningful chunk of revenue is hardware, which comes with manufacturing cost, physical scaling, and lumpier delivery timing.

The growth has been remarkable and is well corroborated. Revenue was roughly $500 million in 2023, doubled to about $1 billion in 2024 (confirmed by Fortune, Axios, CNBC, and The Information), and Notice estimates it reached about $2.1 billion in 2025, consistent with the CEO's own comments that the company expected to go from about a billion to over two billion. Revenue per employee sat near $366,000 in 2025. Triple-digit growth on a base that size is genuinely rare in defense.

Why Are Investors Bullish on Anduril?

The bull case is that Anduril is rewriting how the Pentagon buys. Legacy primes move slowly and build to spec; Anduril builds autonomous, software-defined systems fast and sells them as products. The Lattice platform is the connective tissue, and the more systems it ties together, the stickier the whole ecosystem becomes. With Western defense budgets rising and a clear appetite for cheaper, autonomous, attritable systems, the demand backdrop is strong. The quality of the backers reinforces it, and following which firms lead these rounds is a real signal, though our piece on following top VCs as a strategy explains why that signal works better at some stages than others.

Our very own Hustle Fund GP, Elizabeth Yin, has talked about how differentiation is everything, that a company needs to be 10x different and 10x better than all the alternatives, not just its direct competitors. Anduril's Lattice-plus-autonomy stack is a real attempt at that: not a slightly better missile, but a different operating model for defense, where software and autonomy are the product and the hardware is downstream of it. If that model holds and scales, it is a deep moat. If the primes catch up on software, or if programs get delayed, the differentiation thins.

What Are the Biggest Risks for Anduril Investors?

Two company-level risks carry most of the weight, and both sit underneath that premium price.

Government Concentration and Procurement Cycles

Anduril's revenue depends heavily on US and allied government contracts. That base is lumpy, politically sensitive, and subject to budget cycles, program cancellations, continuing resolutions, and bid protests. A shift in administration priorities, a lost program of record, or a delayed procurement can move the numbers hard. And the incumbents, the traditional primes, are not passive: they have decades of relationships, lobbying muscle, and their own fast-follower software efforts. Deep-tech and defense diligence is its own discipline, closer to what our overview of community due diligence frameworks describes than to evaluating a typical SaaS deal, and it is the kind of work that ecosystems around deep-tech investing are built to teach.

A Premium Price on a Hardware Business

Anduril trades at roughly 29x last-round revenue and about 41x on the secondary, and you are paying a 43% premium on top of an already-aggressive round. That multiple is priced for continued triple-digit growth and flawless execution on capital-intensive hardware scaling, which carries lower gross margins than software and real manufacturing risk. Any growth stumble, margin disappointment, or program slip against that multiple re-rates hard. Paying up to the most optimistic marks leaves little room for error.

The Risks Investors Underprice: Liquidity, Dilution, and Information Asymmetry

Company risk gets the attention. Structural private-market risk is what actually shows up in your returns.

Liquidity risk is the one buyers underprice, and Anduril's indirect-only structure compounds it. With no direct transfers, your exit depends on the vehicle or contract you bought into, not just on the company. Even a future listing brings lockups and volatility. Dilution is real too, through option pools and future financings, and Anduril has raised enormous rounds that keep issuing shares. Information asymmetry is the seller's structural edge: Anduril does not file public quarterlies, so you are often transacting with someone who sees more than you do.

As Elizabeth has noted, valuations are not really about the worth of a company. They are about supply and demand among investors. Anduril is the mirror image of most private names right now. Where a company trading below its last round reflects more sellers than buyers, Anduril's 43% premium reflects the opposite: demand outstripping supply nearly two to one, bidding the price above the primary mark. That is powerful momentum, but it is momentum, and momentum can reverse. Buying into peak demand is a different bet than buying into a discount.

What the Numbers Actually Say

Here is the math, cleanly.

The last primary round priced at about $69 per share for a $61 billion valuation in April 2026. On the secondary market as of early June 2026, Anduril trades near $98.32, a real-time market cap of about $87.24 billion, roughly a 43% premium to that round. That premium is unusual and is the single most important number in the analysis. You are not hunting for a discount here; you are deciding whether the crowd's markup is justified. Our guide on spotting overvalued startups is worth keeping open for exactly this situation.

On revenue, anchor to the well-corroborated 2025 figure of about $2.1 billion. Against the $61 billion round, that is roughly 29x. Against the $87.24 billion secondary market cap, it is about 41x. Now put that next to the public comps. Traditional defense primes like Lockheed Martin and RTX trade around 2x sales, because they grow slowly. Palantir, the closest public defense-and-AI-software analog, trades around 56x to 62x sales in mid-2026, down from a peak near 120x. So Anduril at roughly 29x to 41x sits well above the primes and below Palantir, priced squarely as a high-growth software company rather than a defense contractor. That framing only holds if Anduril keeps growing like software and eventually earns software-like margins on a hardware-heavy business. If the growth rate normalizes, the multiple has a long way to fall. Our breakdown of valuation guidelines for angels walks through how to pressure-test a number like this.

The quarter-by-quarter secondary prints show the enthusiasm: shares ran from the mid-sixties in mid-2025 to the high eighties by year-end, dipped, and pushed back toward $98. Anduril has not disclosed a clear profitability picture, so the case rests on continued growth and eventual margin expansion, not an earnings floor.

The Diligence That Actually Matters: Terms Every Buyer Should Understand

The industry myth is that a headline valuation tells you what you own. In private secondaries, and especially in an indirect structure, the real diligence is the cap table position, the information rights, and the legal structure of what is being transferred.

The terms that decide your outcome: the cap table and your fully diluted ownership, the only honest way to judge a stake; share class, since common and preferred at the same valuation can pay out very differently; liquidation preference, the priority that can leave common with little in a middling exit, and worth understanding in depth given how much Anduril has raised (our note on why liquidation preference actually matters covers it); the option pool, a quiet source of dilution; the 409A valuation, which can sit below a secondary price because tax and liquidity pricing solve different problems; information rights, which common holders and SPV participants often lack; pro rata rights, which most secondary buyers do not get; transfer restrictions, which for Anduril are absolute for direct transfers; and lockup, since your real liquidity event is lockup expiration, not the listing. If a seller or platform cannot explain these clearly for the specific structure being offered, that opacity is itself the risk signal.

Eligibility and Compliance

Most direct private-market offerings are limited to accredited investors, based on income, net worth, or certain credentials. Qualified purchaser status can matter when a deal is packaged through a pooled fund, which for Anduril is the norm rather than the exception given the SPV-only access. Regulation D frames how most of these deals are offered, with Rule 506(b) limiting general solicitation and Rule 506(c) allowing broader marketing but requiring stricter verification. The compliance plumbing, the KYC and AML checks, source-of-funds review, broker-dealer involvement, and escrow, is protective infrastructure, not paperwork friction.

Deal Mechanics: SPVs, Forward Purchases, and the Fee Stack

For Anduril this section is not hypothetical. It is the only way in.

A direct secondary would give you ownership of the shares, but Anduril does not permit that. So you are left with two structures, and both deserve scrutiny.

The first is a forward purchase contract. You are not buying shares. You are buying a contractual promise from a seller to deliver shares, or their value, at a future event like an IPO. That gives you synthetic exposure, and with it counterparty risk. If the seller defaults, cannot deliver, or the underlying transfer never clears, you can be left holding a claim rather than stock. On a name this hot, sellers know their leverage, and you are trusting their ability to perform potentially years out.

The second is a second- or third-layer SPV, a vehicle that invests in another vehicle rather than in Anduril directly. Each layer stacks its own management fee, carry, and admin costs, and each one puts more distance between you and the actual cap table. Two vehicles deep, you may have almost no visibility into the underlying terms and a fee load that quietly eats your return before the company does anything at all. Ask exactly how many layers stand between your money and Anduril's equity, and price each one.

On the fee stack generally, your all-in cost is rarely just the share price. It can include the spread, platform fees, broker-dealer commission, legal review, admin charges, and SPV overhead. On a name trading at a premium, that stack lands on top of an already-elevated entry. An indication of interest is not an allocation, and deals fail for boring reasons. Do not anchor on a deal until cash and shares actually settle.

Where Accredited Investors May Access Anduril Shares in 2026

Access comes almost entirely through pooled and indirect channels. Secondary platforms like Hiive, Forge Global, EquityZen, UpMarket, and Notice surface Anduril exposure, but given the no-direct-transfer rule, what they are offering is SPV or forward-contract access rather than direct shares. Pre-IPO funds hold Anduril alongside other private names and offer diversification at the cost of control. Public proxies are indirect through Anduril's institutional backers. And angel investing communities sometimes surface SPV access to growth-stage and defense-tech deals.

A Note on Research Sources

Research sites can frame valuation narratives and sentiment, but they are not standardized quote systems. Private prices are negotiated snapshots. Anduril's revenue figures, unusually for a private company, are well corroborated across Notice and multiple named outlets, which is a point in their favor. The premium and the indirect structure are the variables to weigh, not the top-line growth.

How This Differs From Early-Stage Venture Access

Late-stage defense secondaries are a different discipline from early-stage venture. Platforms like AngelList and SeedInvest and accelerators like Y Combinator and Techstars build real skill in evaluating founders and product-market fit. An $87 billion defense secondary bought through an SPV is not that. You are underwriting price, structure, and liquidity rather than a founder bet. Still, the discipline transfers, and knowing how long these companies now stay private matters: our piece on why startups stay private longer is directly relevant to sizing an Anduril position.

Liquidity, Lockups, and Exit Paths

Private shares can exit through several paths, each with its own timing and payout for common holders: an acquisition, a tender offer, a direct listing, a conventional IPO, or more years private. For Anduril, the indirect structure adds a layer: your liquidity depends on the vehicle you bought into as much as on the company. Anduril is a widely discussed eventual IPO candidate, but nothing is confirmed, so underwrite a multi-year hold. Position sizing beats conviction in a long-duration private asset, and setting realistic expectations about how and when liquidity actually arrives is part of the work.

Bottom Line

Anduril is one of the most impressive companies in defense: doubling revenue two years running, a genuine platform moat in Lattice, and the strongest demand backdrop in the sector in a generation. It is also the one name here you buy at a 43% premium, through an SPV or a forward contract, at a software multiple on a hardware business, into a crowd bidding two to one. Whether that is opportunity or the top of a momentum trade depends on how you enter: the right structure, a defensible price, sized sensibly, with clear assumptions about liquidity.

Getting that read right is easier when you can see the whole spectrum, from early rounds to complicated late-stage secondaries like this one. That is what Angel Squad is for. It is a community of more than 2,500 accredited investors across 50-plus countries who have collectively invested over $30 million into 70-plus startups, with deal flow spanning pre-seed through pre-IPO. Members get access to the top 1% of deal flow alongside Hustle Fund's GPs, a real no-a-holes policy, and the shared judgment that keeps you honest on exactly these calls. If that is the edge you want, take a look at hustlefund.vc/squad. The investors who do best in private markets stay allergic to hype, read the documents, and remember that structure often matters as much as story.

Frequently Asked Questions

Is Anduril publicly traded? No. Anduril is a private company with no ticker symbol. It also does not allow direct stock transfers, so accredited investors can only get exposure indirectly, through SPVs or forward purchase contracts offered via secondary platforms, pre-IPO funds, or angel investing communities.

What is Anduril's current valuation? Anduril's last primary valuation was $61 billion, set in its Series H round in April 2026 at about $69 per share, led by Andreessen Horowitz and Thrive Capital. On the secondary market it trades closer to an $87 billion market cap, roughly a 43% premium to that round.

How much revenue does Anduril generate? Revenue roughly doubled to about $1 billion in 2024 and again to about $2.1 billion in 2025, figures corroborated across Notice and multiple named outlets. That represents roughly 110% growth in 2025.

Is Anduril profitable? Anduril has not disclosed clear profitability figures. As a hardware-heavy defense business scaling manufacturing, its cost structure is significant, and the investment case rests on continued growth and eventual margin expansion rather than a demonstrated earnings floor.

How can accredited investors buy Anduril stock? Only indirectly, through SPVs or forward purchase contracts, since Anduril prohibits direct transfers. Each path carries different fees, layers, compliance steps, and information rights. Verify how many vehicle layers sit between you and the shares, and confirm the fee stack before transacting.